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Sex determination in mammals requires interaction between the transcription factor GATA4 and its
cofactor FOG2. We have recently described the function of both proteins in testis development beyond
the sex determination stage; their roles in the postnatal ovary, however, remain to be deﬁned. Here, we
use gene targeting in mice to determine the requirement of GATA4 and FOG2 in ovarian development
and folliculogenesis. The results from this study identify an essential role of the GATA4 protein in the
ovarian morphogenetic program. We show that in contrast to the sex determination phase, which relies
on the GATA4–FOG2 complex, the subsequent regulation of ovarian differentiation is dependent upon
GATA4 but not FOG2. The loss of Gata4 expression within the ovary results in impaired granulosa cell
proliferation and theca cell recruitment as well as fewer primordial follicles in the ovarian cortex, causing
a failure in follicular development. Preantral follicular atresia is observed within the few follicles that
develop despite Gata4 deﬁciency. The depletion of the follicular pool in GATA4 deﬁcient ovary results in
the formation of ovarian cysts and sterility.
& 2013 Elsevier Inc. All rights reserved.Introduction
GATA-binding proteins have been implicated as key regulators
of ovarian gene expression. In mammals, six GATA-binding pro-
teins (designated GATA1 to GATA6) have been described. This
family of structurally related transcription regulators use their
double zinc ﬁnger domain to recognize the consensus sequence
(A/T)GATA(A/G), known as the “GATA” motif, in target promoters.
Ovarian expression of three GATA factors, GATA2, GATA4, and
GATA6, has been reported. Among these three proteins, GATA4 has
been studied most extensively because of its contribution to
ovarian development and function. Gata4 is detectable in somatic
cells of the bipotential genital ridge (Anttonen et al., 2003; Defalco
et al., 2011; Heikinheimo et al., 1997) and its expression continues
in somatic cells upon sex determination of both XX and XY gonads
(Ketola et al., 2000). At embryonic day (E)13.5, Gata4 expression
becomes sexually dimorphic: in the testis, GATA4 is notably up-
regulated in the Sertoli cells compared to the interstitial cells,
whereas in the ovary moderate levels of the protein are present inll rights reserved.
Sciences, Basic Science Bldg.
ersity of Florida,
.most somatic cells. In postnatal ovaries, GATA4 is conspicuously
present in somatic cells and is prominently expressed within
granulosa cells; however, GATA4 expression is downregulated in
luteal cells of the corpus luteum (Anttonen et al., 2003).
Another GATA family member, Gata6, is also expressed in both
the somatic and germ cells of the developing ovaries (Heikinheimo
et al., 1997; Lavoie et al., 2004). It has been hypothesized that
GATA4 and GATA6 carry (at least partially) overlapping functions
in gonadal somatic gene regulation [(Robert et al., 2006) and, most
recently, Bennett et al. (2012)]. Alternatively, these GATA proteins
may play non-overlapping roles in ovarian function. In contrast,
Gata2 expression has been documented only in germ cells during a
narrow window of embryonic development (Bhardwaj et al., 2008;
Siggers et al., 2002). Embryos carrying germline homozygous
mutations of Gata genes are lethal before ovarian development
can be examined (Kuo et al., 1997; Molkentin et al., 1997; Morrisey
et al., 1998; Tsai and Orkin, 1997).
The multitype zinc-ﬁnger proteins of the FOG (Friend of GATA)
family can modulate GATA regulatory activities (Tevosian et al.,
2000). FOG1 and FOG2 are the two members of the FOG family in
vertebrates, and FOG2 is the only member present in ovarian
somatic cells. The expression of Fog2 in the developing mouse
gonads starts as early as E11.5 (Svensson et al., 1999; Tevosian
et al., 1999). Subsequent characterization demonstrated that Fog2
expression generally follows that of Gata4 in both sexes until
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testis (Anttonen et al., 2003; Manuylov et al., 2007a). Although the
expression of GATA4 and FOG2 is evident in fetal ovarian somatic
cells, the number of cells expressing FOG2 is less than the number
expressing GATA4 (Anttonen et al., 2003). In the postnatal ovary,
FOG2 is expressed in the granulosa and theca cells of growing
follicles in addition to the luteal cells of the corpus luteum
(Anttonen et al., 2003).
Mouse fetuses carrying null alleles for Fog2 (Fog2−/−) die of
cardiac defects at mid-gestation (Svensson et al., 2000; Tevosian
et al., 2000). Because Fog2−/− embryos survive until approximately
E14.0, analysis of early gonadal development in the absence of
FOG2 has been previously described (Manuylov et al., 2008;
Tevosian et al., 2002). Such analysis is not possible in Gata4−/−
mutants because embryos die at E7.0-E9.5, before the appearance
of the gonadal anlagen. A modiﬁed Gata4 knock-in allele (Gata4ki, a
V217G amino acid substitution) that abrogates the interaction
between GATA4 and FOG2 (Crispino et al., 2001) was instrumental
in establishing the role of GATA4 in mouse fetal development,
including gonadogenesis. Homozygous Gata4ki embryos survive
until E13.0, when they die of cardiac abnormalities similar to those
reported for the Fog2−/− embryos. Analysis of early gonadogenesis
in the Fog2−/− and Gata4ki/ki mutants conﬁrmed that the GATA4 and
FOG2 proteins and their interaction are absolutely required for the
sexual determination of both testes (Tevosian et al., 2002) and
ovaries (Manuylov et al., 2008).
Although the Gata4ki allele provided important insight into the
function of the GATA4 protein during organogenesis, this knock-in
mutation does not result in a loss of Gata4 function. The GATA4ki
protein is speciﬁcally modiﬁed to hinder the binding of FOG
partners, while all other GATA4 functions are expected to remain
intact. Furthermore, the embryonic lethality of the Gata4; Fog2
mutants precludes the examination of gonad development after
birth. This lethality is particularly restrictive for the analysis of the
ovarian developmental pathway because the full outcome of a
gene loss in ovarian development may not be functionally appre-
ciated until sometime after birth. In addition, the study of GATA4ki
mutants established that GATA4 and FOG2 worked as partners
during the sex determination phase (Manuylov et al., 2008) but
provided little insight into whether these proteins have separate
functions later in ovarian development. Thus, the consequences of
GATA4 loss in ovarian development remain to be determined. In
the present study, we evaluated the roles of the GATA4 and FOG2
proteins and their interaction in ovarian development using
conditional mouse models. In these mice, the steroidogenic factor
1/Nr5a1 (Sf1)-driven Cre recombinase (Bingham et al., 2006) limits
the deletion of Gata4 or Fog2 to a subset of progenitor somatic cells
within the gonads. We also generated double Gata4; Fog2 mutants
carrying simultaneous deletions of both genes. We then inspected
the importance of the interaction between GATA4 and FOG2 usingFig. 1. Embryonic expression of ovarian-speciﬁc genes upon Sf1Cre-mediated deletion of G
ovaries at E13.5. Genes examined were Mvh, Sf1, Gata6, Irx3, Fst and Foxl2 and results a
control (B), Sf1Cre; Gata4ﬂoxed/ﬂoxed (C) and Sf1Cre; Fog2ﬂoxed/ﬂoxed (D) E13.5 ovaries were hy
anterior facing the right.the Sf1Cre; Gata4ﬂoxed/ki mice. In these animals, the Gata4ki allele
serves as the sole source for the GATA4 protein (GATA4ki) in
ovarian somatic cells once the recombination of the Gata4 ﬂoxed
allele encoding the wild-type GATA4 protein takes place. Finally,
we took advantage of another mouse strain that carries an
inducible CreERT2 under the control of the Wilms' tumor 1 (Wt1)
promoter (Zhou et al., 2008) to determine the need for GATA4 at
different stages of ovarian development.
Here, we provide evidence that ﬁrmly establishes the impor-
tance of GATA4 in ovarian and follicular development beyond the
sex determination stage. In the absence of GATA4, folliculogenesis
is markedly diminished, which leads to a drastic reduction in the
number of developing follicles shortly after birth, the formation of
ovarian cysts and sterility.Results
Deletion of Gata4 by Sf1Cre produced subtle changes in early ovarian
development
Previous studies of Gata4ki and Fog2 null mutants demon-
strated that a deﬁciency in the GATA4–FOG2 interaction leads
to a block in sex determination and a down-regulation of the
canonical Wnt signaling pathway (Manuylov et al., 2008). How-
ever, how GATA4 and FOG2 act during subsequent ovarian devel-
opment and whether their functions diverge at a later stage both
remain unknown.
To address these questions, we performed Cre-assisted dele-
tions of the Gata4 and Fog2 genes using a Cre recombinase under
control of the Sf1 promoter. In these experiments, Sf1Cre-induced
deletion of the Gata4 and Fog2 ﬂoxed alleles was highly effective
during ovarian development. In the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries,
the reduction in the amount of the GATA4-positive cells was
noticeable as early as E11.5 (data not shown); at E12.5, the GATA4
protein was practically absent from the somatic cells of the gonad.
In contrast, the amount of cells positive for both PECAM-1/CD31, a
protein expressed in endothelial and germ cells, and FOXL2, the
earliest marker of granulosa cells (Schmidt et al., 2004), appeared
similar in wild-type controls and mutant ovaries (Supplemental
Fig. S1A–D). In the Sf1Cre; Fog2ﬂoxed/ﬂoxed, the excision of Fog2 was
not apparent at E11.5, but the expression of the FOG2 protein was
already diminished at E12.5 (data not shown) and markedly
reduced by E13.5 (Supplemental Fig. S1E, F). These data are in
agreement with our previous observations of Gata4 and Fog2
deletions upon Sf1Cre excision in the testis (Manuylov et al., 2011).
To determine the effect of Gata4 or Fog2 deletion during
embryonic ovarian development, ovaries at E13.5 from wild-type
controls and both conditional mutants were analyzed to determine
the expression of ovarian-speciﬁc genes. Quantitative analysis byata4 and Fog2. (A) Quantitative changes in gene expression of Sf1Cre; Gata4ﬂoxed/ﬂoxed
re shown as means7S.E.M of fold change relative to wild-type controls. Wild-type
bridized with RNA probes to Irx3. Gonad (g)-mesonephros (m) are oriented with the
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sion of Sf1 and Mvh genes compared to wild-type controls. Real-
time PCR experiments also demonstrated a signiﬁcant increase
(Po0.01) in the relative expression of Gata6 and signiﬁcant
decrease (Po0.01) in the relative expression of Fst, Irx3 and Foxl2
in the Sf1Cre; Gata4 ﬂoxed/ﬂoxed ovaries (Fig. 1A). Similarly, in situ
hybridization with RNA probes for Irx3, Stra8, Wnt4, Fst, Foxl2 and
Sf1 did not reveal drastic changes in gene expression in the
embryonic ovaries of Gata4 and Fog2 conditional mutants
(Fig. 1B–D and data not shown).
The entrance of oogonia into meiosis is a deﬁning event in
ovarian gonadogenesis. Staining of postnatal day (PND) 1-ovarian
sections for the meiotic marker Synapsin 1 (SYN1) (Dobson et al.,
1994) showed a similar pattern of expression of SYN1 between
oocytes from wild-type control and mutant ovaries (Supplemental
Fig. S2A–C). Likewise, no apparent difference in the pattern of
expression of WT1, another protein expressed in granulosa cells
(Pelletier et al., 1991), was observed between controls and condi-
tional mutants (Supplemental Fig. S2D–F). In addition, inspection
of the developing gonads up to PND 1 did not uncover any notable
changes in either size or morphology between conditional mutant
ovaries and wild-type controls.
In summary, subsequent to the sex determination phase (as
early as E13.5), Gata4 deletion resulted in a detectable alteration in
the expression of genes involved in the ovarian developmentalFig. 2. Histomorphological appearance of wild-type control and conditional mutant ov
with hematoxylin–eosin (H&E) of wild-type control (A, B, I), Sf1Cre; Gata4ﬂoxed/ﬂoxed (C, D
mutant, Sf1Cre; Gata4ﬂoxed/ﬂoxed; Fog2ﬂoxed/ﬂoxed (J) ovaries. Note that the conditional dou
Pregnant females were treated with tamoxifen at E18.5 and ovaries from female offsp
sections stained with H&E of control (K, L) and Wt1CreERT2; Gata4ﬂoxed/ﬂoxed (M, N) ov
deletion (O, P). Numerous GATA4-positive somatic cells (red) were observed in the sect
somatic cells of the Wt1CreERT2; Gata4ﬂoxed/ﬂoxed ovary (P). Scale bars are 200 mm. Nuclepathway, but embryonic ovarian development in Gata4 mutants
appeared to proceed essentially normal.
GATA4 is absent in the early postnatal hypothalamus and pituitary
gland
Sf1 regulatory elements target Cre expression to the somatic cells
of the gonads and to other tissues, including the anterior pituitary
and the ventromedial hypothalamic nucleus (Bingham et al., 2006).
While embryonic ovarian development is independent of hormonal
regulation (Couse et al., 1999; Simpson et al., 2002), in our analysis, it
was essential to rule out the possibility that extra-gonadal Gata4
deletion could have an effect on the ovarian postnatal phenotype (i.e.,
folliculogenesis). Therefore, we examined GATA4 expression in
organs where Sf1Cre is known to be active. To visualize Sf1Cre
activity, we used the ROSA26mT/mG “switch” mice, in which a
membrane-targeted red ﬂuorescent protein (mT) is ubiquitously
expressed before Cre-mediated excision and a membrane-targeted
green ﬂuorescent protein (mG) is expressed upon Cre excision
(Muzumdar et al., 2007). Cells in which Sf1Cre was active were
distinguishable by the expression of the membrane-bound eGFP.
Anti-GATA4 antibody produced no speciﬁc staining in either the
hypothalamus or pituitary at PND 1–8 (Supplemental Fig. S3A–F and
data not shown). The integrity of the pituitary sample was further
corroborated by staining for protein hormones such as α-GSU, TSHaries at PND 30. Gross morphological appearance and histological sections stained
), Sf1Cre; Fog2ﬂoxed/ﬂoxed (E, F), Sf1Cre; Gata4ﬂoxed/ki (G, H) and the conditional double
ble mutant ovary exhibits a similar phenotype to the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovary.
ring were analyzed at PND 28. Gross morphological appearance and histological
aries at PND 28. Efﬁciency of the tamoxifen-induced CreERT2 recombinase-Gata4
ion of the Cre-negative control ovary (O), whereas no staining was observed in the
ar staining (DAPI) is blue.
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(Supplemental Fig. S3G–L and data not shown). In contrast, speciﬁc
GATA4 nuclear staining was easily observed in other tissues (i.e.,
testis, speciﬁcally in Sertoli cells of the seminiferous tubules from an
XY littermate, Supplemental Fig. S3M–O). These data corroborate that
the early ovarian phenotype observed in Sf1Cre; Gata4ﬂoxed/ﬂoxed
mutants (described below) is most parsimoniously explained by
the loss of Gata4 expression within the ovary and not elsewhere.
Only GATA4 is required for ovarian morphogenesis after birth
The Sf1Cre-induced deletion of Gata4 does not affect viability, and
mice lacking expression of GATA4 within the gonads can be analyzed
throughout their lifetimes. Ovaries of Sf1Cre; Gata4ﬂoxed/ﬂoxed mice
remained in their typical position inside the peritoneal cavity,
although they were substantially smaller and the number of follicles
was greatly reduced compared to wild-type control littermates
(Fig. 2A–D). Moreover, when Sf1Cre; Gata4ﬂoxed/ﬂoxed adult females
(n¼10) were housed for 2–8 months with fertile C57BL/6 males,
none of the females developed visible pregnancies or delivered
litters. Mice carrying simultaneous deletions of both the Gata4 and
Fog2 genes were analyzed, and the ovarian phenotype observed for
the Sf1Cre; Gata4ﬂoxed/ﬂoxed; Fog2ﬂoxed/ﬂoxed (conditional double
mutants) was found to be similar to that of Sf1Cre; Gata4ﬂoxed/ﬂoxed
mice (Fig. 2I, J).
In contrast to the ovarian phenotype observed in Sf1Cre;
Gata4ﬂoxed/ﬂoxed and Sf1Cre; Gata4ﬂoxed/ﬂoxed; Fog2ﬂoxed/ﬂoxed mice,
females with Fog2 deletion alone (Sf1Cre; Fog2ﬂoxed/ﬂoxed) were
fertile and indistinguishable from the control littermates
(Fig. 2E, F).
The importance of the GATA4–FOG2 interaction during sex
determination has been established by analyzing fetuses with the
Gata4ki/ki mutation (Manuylov et al., 2008; Tevosian et al., 2002).
Analysis of Sf1Cre; Gata4ki/ﬂoxed ovaries (in which the remaining
GATA4ki isoform expressed by the Gata4ki allele is incapable of
interacting with FOG2) showed no morphological differences with
the wild-type littermates and females were fertile (Fig. 2G, H).
Considering that embryonic ovaries from the Sf1Cre; Gata4ﬂoxed/
ﬂoxed mice had some changes in gene expression but no apparent
changes in meiotic initiation, we hypothesized that the presence of
functional Gata4 becomes essential following birth. To test this
hypothesis, we used the tamoxifen-inducible Wt1CreERT2 mouse
(Zhou et al., 2008). Timed-pregnant Wt1CreERT2; Gata4ﬂox/ﬂox
females were injected at E18.5 (just before birth and initiation of
ovarian folliculogenesis) with tamoxifen to induce Cre excision
and ovaries from the control and mutant offspring were collected
4 weeks later. Staining of ovarian sections from Wt1CreERT2;
Gata4ﬂoxed/ﬂoxed at PND 28 for GATA4 demonstrated that
tamoxifen-induced Cre recombination was highly effective and
no GATA4 expression was detected (Fig. 2O, P). Hematoxylin and
eosin staining of Wt1CreERT2; Gata4ﬂoxed/ﬂoxed sections revealed an
ovarian phenotype similar to the one observed for the Sf1Cre;
Gata4ﬂoxed/ﬂoxed, with smaller ovaries and reduced follicular popu-
lation compared with controls (compare Fig. 2C, D to M, N).
In summary, these data indicate that GATA4 has an essential
function in postnatal ovarian development and differentiation. In
contrast, neither the GATA4–FOG2 partnership nor FOG2 function
itself are necessary for the subsequent ovarian morphogenetic
program.
Loss of Gata4 function affects normal follicular development
It has been documented that major structural and develop-
mental changes within the postnatal mouse ovaries happen during
the ﬁrst two weeks of life. The breaking of the oogonial nests
initiates immediately after the time of birth, and most oocytesbecome surrounded by squamous granulosa cells by PND 3. This
process is described as the formation of primordial follicles, an
important step in the ovarian developmental program that
depends on the intimate interaction between oocytes and pregra-
nulosa cells. Granulosa cells of primordial follicles undergo a
squamous-to-cuboidal transition and completely encircle the
oocyte to advance to the next (primary) follicular stage. An
intermediate (transitional) stage also exists and is deﬁned as a
follicle containing a mixture of cuboidal and squamous granulosa
cells. Primary follicles further progress to a secondary stage in
which two to three layers of granulosa cells accumulate and
surround the developing oocyte and the outermost theca cell layer
is recruited. The timing of follicular recruitment into the pool of
actively developing follicles is not well understood. For example,
while it is clear that the transition from primordial to primary
follicle represents a regulated, irreversible maturation step, it has
also been suggested that all unilaminar follicles (primordial,
transitional and primary) represent the resting population (Da
Silva-Buttkus et al., 2008; Meredith et al., 2000; Parrott and
Skinner, 1999).
Because ovaries from Sf1Cre; Gata4ﬂoxed/ﬂoxed females already harbor
a greatly reduced number of mature follicles at PND 30 (Fig. 2D, J), we
examined the dynamics of folliculogenesis in these mice at earlier
stages of development. At PND 3, sections fromwild-type controls and
Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries revealed follicles at the primordial stage,
in which oocytes are surrounded by ﬂattened granulosa cells, and at
the primary stage, in which the granulosa cells are cuboidal (Fig. 3A–
D). No signiﬁcant difference, however, was observed in the number of
primordial follicles between wild-type controls (4376) and Sf1Cre;
Gata4ﬂoxed/ﬂoxed ovaries (3572) (Fig. 3O). In contrast, the number of
advanced follicles (containing cuboidal cells) was signiﬁcantly reduced
(Po0.001) in the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries (570.3) compared to
those of wild-type littermates (1571) (Fig. 3O). Overall, oocyte
development in PND 3 mutants appeared normal, and the expression
of FOXL2 and the oocyte-speciﬁc protein mouse vasa homolog (MVH)
were comparable between follicles from wild-type control and Sf1Cre;
Gata4ﬂoxed/ﬂoxed follicles (Fig. 3E–H).
At PND 7, numerous primary follicles were present in the wild-
type control ovaries (Fig. 3I, K). In contrast, while follicles contain-
ing cuboidal granulosa cells could be easily observed in the mutant
Sf1CreGata4ﬂoxed/ﬂoxed ovaries, most of them appeared abnormal
and exhibited a transitional phenotype characterized by the
persistence of squamous cells (Fig. 3J, L). Furthermore, while
numerous secondary and higher-order multilayered follicles were
present in the ovarian sections of wild-type controls, few such
follicles were evident in the conditional mutants (Fig. 3I–L).
Quantitatively, ovaries at PND 7 revealed a signiﬁcant reduction
(Po0.001) in the number of developing follicles (1370.8 vs.
2771.4) between the Sf1Cre; Gata4ﬂoxed/ﬂoxed and wild-type con-
trol ovaries, whereas the number of primordial follicles in condi-
tional mutants was signiﬁcantly higher (Po0.001) compared to
wild-type controls (4872.2 and 2071.8, respectively) (Fig. 3P).
Previously, GATA4 has been shown to act as a regulator of cell
growth and proliferation in tissues other than the gonads
(Agnihotri et al., 2009; Rojas et al., 2008; Singh et al., 2010;
Trivedi et al., 2010; Zeisberg et al., 2005). To determine whether
ovaries from conditional mutants have altered cell proliferation or
apoptosis, we performed BrdU-labeling (Fig. 3M, N) and TUNEL
analysis. In the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries at PND 7, the
number of proliferating somatic cells was signiﬁcantly reduced
(Po0.001) (8675.7) compared to controls (22579) (Fig. 3Q).
There was, however, no difference in the number of apoptotic cells
between wild-type controls and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries
(data not shown).
To explore whether Gata4 deletion by Sf1Cre directly affected
granulosa cells or had an indirect effect on oocyte development,
Fig. 3. Gata4 loss disrupts normal follicular development. Sections (A–H) of wild-type control (left; A, C, E, G) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (right; B, D, F, H) ovaries at PND
3 were stained either with H&E (A–D) or for the germ cell marker, MVH (red; E, F) or the granulosa cell marker, FOXL2 (green; G, H). Panels C and D are higher magniﬁcation
of sections A and B, respectively. Sections (I–N) of wild-type controls (I, K, M) and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries (J, L, N) at PND 7. Sections in panels I and J were stained with
H&E and panels K and L are higher magniﬁcations of sections I and J, respectively. Primordial and primary follicles are shown by arrowheads. PA, preantral follicle. Analysis of
cell proliferation in the wild-type control (M) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (N) ovaries from mice treated with BrdU. Sections were stained with an antibody against BrdU
(green) and DAPI (blue) for nuclear staining. Note the decrease in BrdU-positive cells in the conditional mutant ovary (N). Scale bars in panels C, D, K and L are 20 mm and in
all other panels 100 mm. Quantitation of follicles and proliferating cells in wild-type control and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries. (O) Total number of primordial and
developing follicles at PND 3 in wild-type (WT) control (black) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (gray) ovaries. (P) Total number of primordial and developing follicles at PND 7 in
wild-type control and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries. (Q) Total number of BrdU-positive cells in wild-type control and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries. The data are presented
as means7S.E.M. from three independent samples (n¼3) of each genotype (wild-type control and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries). **Po0.001.
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markers. Anti-Müllerian hormone (AMH) is expressed at speciﬁc
follicular stages and is ﬁrst detected in primary follicles; its
expression peaks in granulosa cells of preantral and small antral
follicles (Durlinger et al., 2002a, 1999, 2002b; Visser et al., 2006).
Staining of sections with an antibody against AMH showed that
wild-type ovaries possessed numerous AMH-positive follicles,
while very few cells in the Sf1Cre; Gata4ﬂoxed/ﬂoxed mutants were
positive for AMH (Fig. 4A, B). 3-beta hydroxysteroid dehydrogen-
ase (3ßHSD) was also found to be robustly expressed by granulosa
cells in wild-type control ovaries (Fig. 4C), in which the expression
was low in primary follicles but increased in follicles that had
become multilayered. In contrast, in the Sf1Cre; Gata4ﬂoxed/ﬂoxed
ovary, the expression of 3ßHSD was hardly detectable (Fig. 4D).
Oocyte development appeared normal in the conditional
mutant, and the expression of oocyte-speciﬁc proteins (MVH and
GDF-9) was comparable between wild-type controls and Sf1Cre;
Gata4ﬂoxed/ﬂoxed oocytes (Fig. 4A, B, E, F). However, the ovarian
cortex of the Sf1Cre; Gata4ﬂoxed/ﬂoxed was depleted of primordial
follicles compared to wild-type controls (Fig. 4A, B).At PND 9, follicles in the wild-type ovaries continued to express
AMH abundantly whereas in Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries, AMH
staining was restricted to a few transitional primary follicles that
were able to form in the absence of Gata4 (Fig. 5A–F). We also
noted that in wild-type ovaries, WT1 and 3ßHSD were abundantly
expressed by granulosa cells of multilayered follicles (Fig. 5G, I, K).
Moreover, expression of 3ßHSD in theca cells surrounding pre-
antral follicles was also clearly visible in control ovarian sections
(Fig. 5I, K). This observation suggests that the majority of the
follicles had advanced out of the quiescent (primordial) pool.
However, in the mutant Sf1Cre; Gata4ﬂoxed/ﬂoxed sections, most
follicles were still in the primordial and transitional primary stage,
and multilayered follicles surrounded by positive 3ßHSD-theca
cells were very rare (Fig. 5H, J, L) because transitional primary
follicles do not express 3ßHSD. While Gata4 loss in Sf1Cre;
Gata4ﬂoxed/ﬂoxed ovaries was comprehensive, rare somatic cells
retain GATA4 expression (Supplemental Fig. S4A–F).
In summary, morphological and molecular analysis indicates
that formation of primordial follicles initiates normally, but sub-
sequent follicular development is severely constrained by the loss
Fig. 4. Ovarian expression of granulosa and germ cell proteins at PND 7. Sections of wild-type control (left; A, C, E) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (right; B, D, F) ovaries were
stained for AMH (red) and MVH (green) (A and B); 3ßHSD (red) and GATA6 (green) (C and D) or GDF-9 (green; G and H). Note the reduction in expression of AMH and 3ßHSD
in the ovaries from the conditional mutant animals. Additionally, numerous follicles are present in the ovarian cortex of the wild-type control (white arrows in panel A) but
absent in the conditional mutant, which also exhibits a decrease in advanced-stage follicles (B). The expression of MVH, GATA6 and GDF-9 in germ cells appeared similar
between wild-type controls and conditional mutant ovaries.
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conditional GATA4 mutant is associated with a decrease in cell
proliferation, a decreased number of primordial follicles in the
cortex and a marked reduction in the somatic ovarian expression
of AMH and 3ßHSD.
Characterization of adult ovaries at PND 90, 120 and 180
Inspection of adult ovaries from wild-type controls, Sf1Cre;
Fog2ﬂoxed/ﬂoxed and Sf1Cre; Gata4ﬂoxed/ki mice showed a normal and
healthy gross appearance (Fig. 7A, C). By contrast, ovaries from
Sf1Cre; Gata4ﬂoxed/ﬂoxed mice were smaller and had visible cavities
apparently ﬁlled with follicular ﬂuid (Fig. 7E). Histological analysisof the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries at PND 90, 120 and 180
revealed a few remaining follicles at the preantral and antral
stages as well as hemorrhagic follicles and large cystic structures
(Figs. 6C, E, F and 7F). These remaining follicles were not the result
of the incomplete excision of Gata4, as they were negative for
GATA4 staining (Supplemental Fig. S4A–D). Thus, the deletion of
Gata4 by Sf1Cre results in an extensive block in follicular devel-
opment and the subsequent loss of follicles.
We also noted an abundance of autoﬂuorescent particles in the
Gata4 conditional mutant ovaries. These inclusion bodies could be
detected as early as PND 30 (data not shown) but were especially
prominent during adulthood and resembled the accumulation of
lipofuscin (Supplemental Fig. S5B). Lipofuscin is known as an aging
Fig. 5. Arrested follicles in ovaries of the conditional mutants express AMH, but not 3ßHSD at PND 9. Sections of wild-type control (A, C, E) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (B, D,
F) ovaries stained for AMH (green; A–F) and WT1 (red; C–F). Panels E and F are higher magniﬁcations of C and D, respectively. Staining of ovarian sections from wild-type
controls (G, I, K) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (H, J, L) with antibodies against WT1 (red; G, H, K, L) and 3ßHSD (green; I, J, K, L). Note that few transitional follicles in the Sf1Cre;
Gata4ﬂoxed/ﬂoxed (asterisks in panels F and L) express AMH (B, D, F), but not 3ßHSD (J, L). Additionally, note in Panels J and L the lack of theca cells surrounding preantral
follicles.
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that accumulate in aged, postmitotic cells (Zimon et al., 2006). The
presence of lipofuscin inclusions was further conﬁrmed by stain-
ing sections of Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries with Sudan Black
(Supplemental Fig. S5D).
Early follicular atresia in the Gata4 conditional mutant ovaries
Once follicles reach the antral stage, they are either selected for
ovulation or become atretic and undergo cell death (Matsuda et al.,
2012). To determine the stage when follicles undergo atresia, adult
ovarian sections (PND 90 and 120) from wild-type controls and
Sf1Cre; Gata4ﬂoxed/ﬂoxed mice were stained for active caspase-3
(CASP3) and AMH. At both time points examined, preantral
follicles of wild-type control ovaries had very few CASP3 positive
cells, in which the majority of apoptotic cells were localized
among granulosa cells of atretic antral follicles and luteal cells of
regressing corpora lutea (Fig. 8A, B, E, F and data not shown).
In contrast, in the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries, active CASP3
positive cells were easily observed among granulosa cells, theca
cells of preantral follicles, in the few follicles that reached the antral
stage and in the luteal cells of the corpus luteum (Fig. 8C, D, G, H
and data not shown). Likewise, in sections of the Sf1Cre; Gata4ﬂoxed/
ﬂoxed ovaries, we noticed the presence of cystic structures as well as
autoﬂuorescent particles that presumably contained lipofuscin.
Characterization of the cysts in the Gata4 conditional mutants
Inclusion cysts, which are frequently observed in ovarian
epithelial cancer, are generally thought to arise from either the
coelomic-derived surface epithelium or the interconnecting
epithelial cords and tubules of the intra-ovarian rete located
within the hilum of the ovary (Tan et al., 2005). Previous studiesdemonstrated that GATA4 is strongly expressed in epithelial cells
of ovarian surface epithelium (OSE) (Capo-chichi et al., 2003).
To determine the origin of cysts observed in conditional mutants
(Figs. 6C, E, F and 7F), we used antibodies against laminin and pan-
cytokeratin, the latter of which recognizes a common epitope on
the Type II cytokeratins. Epithelial cells typically express cytoker-
atin and are lined by a layer of laminin-positive basement
membrane. We observed positive staining for both proteins
(Fig. 9E, F), consistent with the epithelial origin of these cells.
Unlike OSE, which is devoid of cilia, cells of the ovarian rete
epithelium expose multiple motile cilia on their apical surfaces
(Long, 2002; Tan et al., 2005). Staining for acetylated α-tubulin, a
well-known marker of the ciliary axoneme, demonstrated that
epithelial cells underlying the ovarian cysts in conditional mutant
ovaries expressed cilia on their apical surface (Fig. 9C, D). We also
observed the internalization of ciliated crypts in the region of the
ovarian hilum as early as PND 30 (Fig. 9A, B). Together, these data
strongly suggest that the ovarian cysts observed in the Gata4
conditional mutants originate not from the OSE but instead from
epithelial cells of the intra-ovarian rete. Finally, to show that the
cysts were not immature antral follicles, ovarian sections were
stained for FOXL2, which was detected in the granulosa cells of the
remaining follicles as well as in the luteal cells of the corpus
luteum, but not in the cells underlying ovarian cysts in the Gata4
mutants (Supplemental Fig. S6). During the reproductive cycle in
mammals, ovarian inclusion cysts form periodically and are sub-
sequently eliminated by apoptosis (Ghahremani et al., 1999).
Apoptosis in the ovarian epithelial cells is under follicular control
(Slot et al., 2006a, 2006b). Given the drastic decrease in the
number of follicles in the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries, we
hypothesize that the formation of at least some cysts likely
originates from the failure of this epithelial turnover process when
it is no longer guided by the normal follicular cycle.
Fig. 6. Histological sections of wild-type control and conditional mutant ovaries at PND 90 and 120. Representative histological sections stained with hematoxylin–eosin
(H&E) of wild-type controls (A, D), Sf1Cre; Gata4ﬂoxed/ki (B) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (C, E, F). Asterisks denote ovarian cysts in panels C, E and F. Arrowhead shows a
hemorrhagic follicle. PA, preantral follicle; EA/A, early antral/antral follicle. Scale bars are 200 mm.
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cannot be rescued by exogenous gonadotropins
To assess the response of wild-type controls and Sf1Cre,
Gata4ﬂoxed/ﬂoxed ovaries to exogenous gonadotropins, we performed
a super-stimulation protocol in sexually immature mice (PND 30)
by treating them with PMSG, followed by hCG 48 h later. Ovaries
from Sf1Cre, Gata4ﬂoxed/ﬂoxed were notably smaller compared to
those of wild-type controls (Fig. 10A–D). Moreover, control ovaries
responded to exogenous gonadotropins as was expected by
producing a large number of preantral and antral follicles and
several corpora lutea (Fig. 10A, B). In contrast, in the Sf1Cre,
Gata4ﬂoxed/ﬂoxed ovaries, a great number of follicles were still at
the primordial and primary stage of folliculogenesis and few
follicles reached the antral stage (Fig. 10C, D). Few corpora lutea
developed and some hemorrhagic follicles were observed in the
conditional mutant ovaries, whereas no hemorrhagic follicles were
found in control ovaries. These results demonstrate that normal
follicular development cannot be induced (rescued) by exogenous
gonadotropins in the Gata4 conditional mutant ovaries.Discussion
We have previously shown that the GATA4–FOG2 complex and
the FOG2 cofactor are required for embryonic ovarian develop-
ment. Speciﬁcally, ovarian differentiation was arrested at the sex
determination stage, and genes involved in ovarian somatic cell
differentiation, including Foxl2, Wnt4 and Fst, were not expressed
in gonads from either Fog2−/− mice or Gata4ki/ki fetuses (Manuylov
et al., 2008). In the present work, the roles of GATA4 and FOG2 in
ovarian development were evaluated by the use of conditional
deletions of both Gata4 and Fog2 genes and the outcomes were
compared. We now demonstrate that in contrast to the sex
determination phase, which relies on the functional GATA4–
FOG2 complex, postnatal regulation of ovarian development is
contingent upon GATA4 but not FOG2. The loss of Gata4 expres-
sion results in impaired granulosa cell proliferation and the failure
of follicular development. We also demonstrate that, unlike germ-
line Gata4ki or Fog2 null mutations, conditional deletion of Gata4by Sf1Cre produces negligible effects during ovarian embryonic
differentiation. We observed no apparent changes in either size or
gross morphology of embryonic and neonatal Gata4 conditional
mutant ovaries, although the expression of genes involved in
ovarian differentiation was subtly altered. Meiosis appeared to
initiate and proceed normally in the Gata4 conditional mutants
(Supplemental Fig. S2).
Ovarian differentiation is believed to initiate concurrently with
that of the testis at approximately E11.5, coincidental with the
expression of FOXL2 in a subset of XX somatic cell precursors.
During this time, GATA4 is still present in the Sf1Cre; Gata4ﬂoxed/ﬂoxed
gonads (Manuylov et al., 2011), and it is likely that this residual
GATA4 activity is adequate to ensure the commitment of a sufﬁcient
number of somatic progenitor cells to become granulosa cells. To
characterize the phenotype of GATA4 loss of function during the sex
determination period, an approach different from the Sf1Cre-
mediated deletion will be required. Nonetheless, the data presented
here strongly argue that GATA4 is no longer required in embryonic
ovaries once the sex determination checkpoint is cleared. This
ﬁnding is notably different from the situation in the male gonads,
where GATA4 is required to maintain the expression of speciﬁc
genes in Sertoli cells and testis development throughout embry-
ogenesis (Manuylov et al., 2011).
In contrast to the embryonic stage, postnatal gonads from
female Sf1Cre; Gata4ﬂoxed/ﬂoxed mice revealed prominent conse-
quences of GATA4 loss within the ovary, where delayed follicular
development becomes noticeable as early as day 3. To reveal the
molecular mechanism for the disruption in follicular development
in Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries, we examined protein expression,
cell proliferation and cell death between PND 7 and 9. At these
stages, notable decreases in both ovarian size and follicular devel-
opment were observed. Markers of differentiated granulosa cells,
such as AMH and 3ßHSD, were restricted to the few follicles that
could develop in the conditional mutant ovaries. The reasons for the
partial rescue of follicular development in Sf1Cre; Gata4ﬂoxed/ﬂoxed
ovaries are not clear; however, another GATA family member,
GATA6, is expressed in ovarian somatic cells and may be able to
partially rescue follicle development in the absence of GATA4
(Bennett et al., 2012). In this respect, Gata6 expression in the Sf1Cre;
Gata4ﬂoxed/ﬂoxed embryonic ovaries was up-regulated. Additionally,
Fig. 7. Histomorphological appearance of wild-type control and conditional mutant ovaries at PND 180. Gross morphological appearance and histological sections stained
with hematoxylin–eosin (H&E) of wild-type control (A, B), Sf1Cre; Fog2ﬂoxed/ﬂoxed (C, D) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (E, F) ovaries. Asterisks denote ovarian cysts in panel F.
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from a recently proposed alternative source of granulosa cells in the
adult female (Mork et al., 2011). Furthermore, results from the BrdU
labeling experiments revealed a signiﬁcant decrease in somatic cell
proliferation in the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries. Together, these
data suggest that Gata4 is required in the ovary to promote
granulosa cell proliferation and to generate granulosa and theca
cells in sufﬁcient numbers to advance follicle development beyond
the primary stage. Similarly, Gata4 has been shown to regulate
cardiomyocyte proliferation by directly binding and activating the
Cyclin D2 and Cdk4 promoters (Rojas et al., 2008).
As described above, folliculogenesis in the GATA4 conditional
mutant ovaries is severely reduced but not completely abolished.
The few follicles that do persist achieve preantral and small antral
stages and express AMH and 3ßHSD, but not GATA4 (Figs. 3 and 4
and Supplemental Fig. S4). This observation supports theconclusion that in Sf1Cre; Gata4ﬂoxed/ﬂoxed early postnatal ovaries,
the absence of AMH/3ßHSD-positive follicles represents a com-
prehensive failure for the majority of the granulosa cells to
advance to the next developmental stage, not a loss of GATA4-
dependent AMH- or 3ßHSD transcriptional regulation in otherwise
normal granulosa cells. This suggests a broad function of GATA4 in
regulating the maturation of postnatal granulosa cells. Genes
expressed at this developmental stage of follicular development
have not been well-characterized (e.g., 3ßHsd; (Lavoie and King,
2009)). Given the reduction in AMH expression in the conditional
mutant ovaries, the data presented here are consistent with
previous observations that AMH could act to protect the primor-
dial follicle niche in the ovarian cortex (Durlinger et al., 2002b).
During subsequent stages of development (e.g., PND 30), the
Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries were notably smaller and contained
few follicles; after PND 90, the ovary size decreased approximately
Fig. 8. Preantral follicular atresia in the Gata4 conditional mutant ovaries. Representative sections of wild-type controls (A, B, E, F) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (C, D, G, H)
ovaries at PND 90 (A, B, C, D) and 120 (E, F, G, H) stained for active CASP3 (red) and AMH (green). In control ovaries, active CASP3-positive cells were localized in granulosa
cells of atretic antral follicles and very few CASP3 positive cells in early antral follicles. In the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries active CASP3-positive cells were detected in
granulosa and theca cells of preantral follicles. In Panels G and H, arrows indicate autoﬂuorescent particles (presumably lipofuscin) and asterisks denote cystic structures in
sections of the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries. PA, preantral follicle; EA/A, early antral/antral follicle; At, atretic antral follicle. Nuclear staining (DAPI) is blue.
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large ovarian cysts were easily detected in ovaries of animals older
than 3 months. Not surprisingly, Sf1Cre; Gata4ﬂoxed/ﬂoxed females
were sterile. Similar phenotypes have been described in several
mouse models with ovarian deﬁciency, including mice with Cyp19
(aromatase) gene deletion (Britt et al., 2000) or mice carrying a
constitutively active FSH receptor (Peltoketo et al., 2010), which
likely reﬂects the presence of macrophages during massive ovarian
tissue degeneration in these animals. Similarly, ovaries with
hemorrhagic follicles have been previously described in mice with
follicular degeneration (Peltoketo et al., 2010).
Ovarian cells are thought to undergo cell death by several
mechanisms, including apoptosis, autophagy, necrosis or corniﬁ-
cation (Young and McNeilly, 2010). Apoptosis occurs in antral
follicles not selected for ovulation that become atretic (Matsuda
et al., 2012). In this study, we showed that follicles from Sf1Cre;
Gata4ﬂoxed/ﬂoxed adult ovaries underwent early atresia. As detected
by an active CASP3 antibody, apoptotic cells were identiﬁed among
granulosa and theca cells of preantral follicles. Moreover, numer-
ous apoptotic cells were detected among the granulosa cells of
rare follicles that reached the antral stage. While we cannot deﬁne
the ultimate fate of the primordial and primary follicles that form
in the absence of Gata4, it is likely that once their development is
arrested, they are eliminated through apoptosis.
In contrast to mice with the Gata4 deletion, Sf1Cre-mediated
loss of Fog2 within the ovary does not result in any discernible
phenotype. The Sf1Cre; Fog2ﬂoxed/ﬂoxed females are fertile and
deliver normal, fertile offspring. In comparison, their male litter-
mates carrying the Sf1Cre-mediated deletion of Fog2 are sterile
and undergo sex reversal (Manuylov et al., 2011). Similarly, in
contrast to Sf1Cre; Gata4ﬂoxed/ﬂoxed mice, Sf1Cre; Gata4/ﬂoxed/ki
females are fertile. Absence of the phenotype in these animals
carrying a Gata4ki mutation in addition to the Sf1Cre-mediated
Gata4 loss further strengthens the conclusion that FOG2 and
GATA4–FOG2 interaction are dispensable for postnatal ovarian
development. Indeed, it could be argued that the absence of an
ovarian phenotype in female Sf1Cre; Fog2ﬂoxed/ﬂoxed mice compared
to Gata4 deletion is due to a delay or incomplete deletion of Fog2
at E12.5 (Supplemental Fig. S1E, F). However, in the Sf1Cre;
Gata4ﬂoxed/ki mice, it is the “ﬂox” Gata4 allele that is deleted, whilethe remaining Gata4ki allele produces a protein incapable of
binding FOG2.
We have previously described the constitutional Fog2 null and
Gata4ki (where GATA4–FOG2 complex never forms) genotypes. In
these animals, a loss of the early ovarian gene expression program
is followed by a concomitant block in the pathway of granulosa
cell differentiation (Manuylov et al., 2008). Those data deﬁne the
GATA4–FOG2 complex as a key constituent in the initiation of
ovarian-speciﬁc gene expression program, ovarian sex determina-
tion and the establishment of the granulosa cell fate. However,
once the sex determination stage is completed, neither protein is
required to maintain gene expression or embryonic development
of the ovary. A similar situation occurs during the SOX9-
dependent regulation of testis development where, despite its
central role in the initiation of the male program, Sox9 becomes
dispensable after E14.5 (Barrionuevo et al., 2009; Chang et al.,
2008). After birth, however, the process of folliculogenesis
imposes an extensive, novel set of demands on ovarian cells
requiring activation and possibly reemergence of transcriptional
regulatory proteins to control gene expression, extensive cell
proliferation and organ remodeling. At this time, GATA4 is called
upon to regulate genes required for granulosa cell proliferation
and theca cell recruitment. The loss of GATA4 caused a reduction
in the number of developing follicles shortly after birth with
subsequent cellular loss, formation of hemorrhagic follicles, ovar-
ian cysts and therefore sterility.
Recently, Bennett et al. (2012) and Kyrönlahti et al. (2011) deleted
Gata4 in proliferating granulosa cells using Cyp19- or Amhr2-Cre,
respectively (the recombination mediated by these Cre drivers is
inefﬁcient within the ovary until after birth) (Bennett et al., 2012;
Kyrönlahti et al., 2011). Intriguingly, the Amhr2Cre; Gata4ﬂoxed/ﬂoxed
adult ovaries had a similar phenotype to the Sf1Cre; Gata4ﬂoxed/ﬂoxed
ovaries with cyst formation and other reproductive defects such as
impaired fertility (Kyrönlahti et al., 2011). Immature Amhr2Cre;
Gata4ﬂoxed/ﬂoxed mice exposed to exogenous gonadotropins had small
ovaries with hemorrhagic follicles and cystic structures on the
ovarian surface (Kyrönlahti et al., 2011). A similar phenotype was
observed in ovaries from immature Sf1Cre; Gata4ﬂoxed/ﬂoxed mice
treated with gonadotropins. Furthermore, follicular development
was not rescued by exogenous gonadotropins in Sf1Cre; Gata4ﬂoxed/
Fig. 9. Epithelial cysts in the Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries are derived from the ovarian rete. Sections of Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries at PND 30 stained with either H&E
(A) or an antibody against acetylated α-tubulin (B). Arrowheads indicate ciliated epithelial cells, arrows point the direction of epithelial invagination and dashed circles
denote cysts. Ovarian sections of Sf1Cre; Gata4ﬂoxed/ﬂoxed at PND 180 stained for either acetylated α-tubulin (green; C), laminin (red; F) or pan-cytokeratin (green; E).
Arrowheads in panels C–F show ovarian epithelial cells and asterisks denote ovarian cysts. Panel D shows a higher magniﬁcation of a boxed area inside panel C.
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still at the primordial and primary stage of folliculogenesis. In
agreement, low levels of estradiol were detected in Cyp19Cre;
Gata4ﬂoxed/ﬂoxed females after stimulation with gonadotropins
(Bennett et al., 2012). These results, taken together with the data
obtained in this study, clearly demonstrate the important role of
GATA4 in ovarian development and function.
Studies using genetically modiﬁed animals have identiﬁed
genes associated with ovarian dysfunction in humans, including
Fmr1, Diaph2, Pof1b, Foxl2, Bmp15, Nobox, Figla and Sf1 (reviewed
in Persani et al., 2010). These studies also suggest a direct link
between fetal development and adult disease, as mutations in
these genes disrupted the assembly and maturation of follicles in
the developing ovary.Conclusions
In this study, we show that the loss of GATA4, a key transcription
factor that controls embryonic ovarian differentiation, results in
sterility in female mice. We have demonstrated that GATA4 is essential
for the regulation of speciﬁc steps during ovarian morphogenesis
independent of its interaction partner, FOG2. Conditional deletion of
Gata4 within the ovary induced a failure of normal follicular devel-
opment and differentiation, with reduced numbers of primordial
follicles in the ovarian cortex and a defect in granulosa cell and theca
cell recruitment. Mice with a conditional deletion of Gata4 represent a
novel genetic model for studying ovarian cystogenesis. Exploring
downstream targets of GATA4 regulation should reveal novel genes
critical to ovarian differentiation and development.
Fig. 10. Follicular development cannot be rescued by exogenous gonadotropins in the Gata4 conditional mutant ovaries. Representative histological sections stained with
hematoxylin–eosin (H&E) of ovaries from wild-type controls (A, B) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (C, D) immature mice (PND 30) that were subjected to a super-stimulation
protocol with PMSG followed by hCG 48 h later. Panels E and F are higher magniﬁcations of C and D. Primordial and primary follicles were present in the conditional mutant
ovaries (shown by arrowheads). Asterisk denotes a hemorrhagic follicle. PA, preantral follicle; EA/A, early antral/antral follicle; CL, corpus luteum. Scale bars are 200 mm (A, B,
C, D) and 100 mm (E, F).
E. Eﬁmenko et al. / Developmental Biology 381 (2013) 144–158 155Materials and methods
Generation of mouse strains
Gata4ﬂox/ﬂox(Zeisberg et al., 2005), Fog2ﬂox/ﬂox (Manuylov et al.,
2007b) and Gata4ki (Crispino et al., 2001) mice were maintained on a
mixed 129/C57BL/6 genetic background. Both Cre lines were main-
tained on a mixed 129/C57BL/6 background. The Sf1Cre transgenic
mice (a kind gift from Dr. Keith Parker), in which a bacterial artiﬁcial
chromosome (BAC) harboring Sf1 regulatory elements directs Cre
expression to the somatic cells of the gonads (as well as to a limited
number of extra-gonadal tissues), have been previously described
(Bingham et al., 2006). To produce strains with Sf1Cre-mediated
deletions, “ﬂox” mice were crossed with Sf1Cre-containing animals.
The resulting Sf1Cre; Gata4ﬂoxed/+ and Sf1Cre; Fog2ﬂoxed/+ males
were backcrossed with Gata4ﬂox/ﬂox and Fog2ﬂox/ﬂox females to gen-
erate conditional mutants with gonad-speciﬁc deletions (Sf1Cre;
Gata4ﬂoxed/ﬂoxed and Sf1Cre; Fog2ﬂoxed/ﬂoxed). To obtain mutants withgonad-speciﬁc loss of the GATA4–FOG2 interaction, Sf1Cre; Gata4ki/+
females were crossed with Gata4ﬂox/ﬂox males. Upon the excision of
Gata4 by Sf1Cre, the Gata4ki allele remained as the only functional
Gata4 allele in the somatic cells of the progeny. TheWt1CreERT2 line
was obtained from the Jackson Laboratories and was previously
described (Zhou et al., 2008). Wt1CreERT2 mice were used to obtain
the Wt1CreERT2; Gata4ﬂoxed/ﬂoxed inducible line of conditional
mutants via an approach similar to the one described above for
Sf1Cre animals. Mice were genotyped with primers listed in the
Supplemental Table S1.
For timed pregnancies, noon of the day of plug observation was
designated as E0.5. Timed-pregnant Wt1CreERT2; Gata4ﬂox/ﬂox
females were injected at E18.5 (just before birth and initiation of
ovarian folliculogenesis) intraperitoneally with tamoxifen (Sigma-
Aldrich, St. Louis, MO) dissolved in corn oil at a dose of 0.2 mg/g
of body weight. Four weeks later, ovaries from the offspring
were collected in 4% (w/v) paraformaldehyde. All experiments
were performed under approved animal protocols in accordance
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tional Animal Care and Use Committees (IACUC).
In situ hybridization
In situ hybridization analysis was performed as previously
described (Manuylov et al., 2007a). The Wnt4 and Fst RNA probes
have been described (Manuylov et al., 2008; Tevosian et al., 2002)
and the Irx3-fragment-containing vector was a gift from Dr. Nef
(Nef et al., 2005).
RNA extraction
Total RNA was extracted from Sf1Cre; Gata4ﬂoxed/ﬂoxed E13.5
ovaries using TRIzols reagent (Invitrogen, Carlsbad, CA) following
the manufacturer's instructions, and concentration was deter-
mined using a NanoDrop Lite (Thermo Fisher Scientiﬁc Inc.,
Waltham, MA). Genomic DNA contamination was removed by
treating RNA samples with DNase I (New England Biolabs, Ipswich,
MA) according to the vendor's speciﬁcations.
Quantitative RT-PCR (qPCR)
The M-MLV (Moloney Murine Leukemia Virus) Reverse Tran-
scriptase kit (Invitrogen) was utilized to synthesize complemen-
tary DNA from total RNA with oligo-dT primers, following the
manufacturer's recommendations. The primers used for qPCR
were manufactured by Integrated DNA Technologies (San Diego,
CA) and are listed in Supplemental Table S2. qPCR reactions were
performed with SYBR Green PCR master mix (Applied Biosystems,
Foster City, CA) in a total volume of 20 ml containing 1 ml of cDNA.
Transcript levels were analyzed on an ABI7500 real-time PCR
system (Applied Biosystems) over 40 cycles of 95 1C for 15 s
and 60 1C for 1 min in a 2-step thermal cycle, preceded by two
initial steps: 2 min at 50 1C and 10 min at 95 1C. Glyceraldehyde
3-phosphate dehydrogenase (Gapdh) served as the normalizing
gene to standardize qPCR data. Samples were analyzed in dupli-
cates from at least 3 biological replicates, and the fold change was
calculated by the ΔΔCt method. The Student's t-test (two-tailed)
was utilized for statistical analysis with signiﬁcance considered at
P40.05. The data analyzed were ΔCt values and results were
plotted as fold-change differences using the GraphPad Prism (5.02
version) software.
Immunoﬂuorescence
Immunoﬂuorescence experiments were carried out on 7 mm
cryosections of ovaries. After permeabilization and blocking [5%
(w/v) nonfat dry milk; 0.15% (v/v) Triton X-100 dissolved in
Dulbecco's phosphate buffered saline (Sigma-Aldrich)], sections
were incubated for 1 h with the following primary antibodies:
AMH, 3ßHSD, GDF-9 (1:500) and acetylated g-tubulin (1:1000)
from Santa Cruz Biotechnologies; GATA6 and MVH (1:300) from
Abcam; Cytokeratin, pan (1:500; Sigma-Aldrich); FOXL2 (1:300;
Everest Biotech); GATA4 N-terminal antibody (1:500; R&D); Lami-
nin (1:500; Molecular Probes); WT1 (1:500; Epitomics) PECAM-1/
CD31 (1:500; BD Biosciences); SYN1 (1:300; a gift from P.B.
Moens). Sections were then incubated for 1 h with the corre-
sponding Alexa Fluor 488- and Alexa Fluor 555-conjugated sec-
ondary antibodies (1:500; Invitrogen). All antibodies were diluted
in Dako antibody diluent (Dako). Slides were mounted in Vecta-
shield containing DAPI (Vector Laboratories) and images were
taken on an Olympus BX51 microscope. Pictures shown are
representative images of n¼3 from each genotype.Hematoxylin and eosin (H&E) staining
Ovarian section of 6 mm of thickness were dewaxed and
rehydrated followed by staining with modiﬁed Harris Hemotox-
ylin (Thermo Fisher Scientiﬁc Inc., Waltham, MA). After staining
differentiation with acid-alcohol [1% (v/v) HCl in 70% (v/v) etha-
nol], Eosin-Y (Thermo Scientiﬁc) was used for counterstaining and
Permount (Fisher Scientiﬁc) as mounting media. Pictures shown
are representative images of either n¼2 or 3 from each genotype.
Quantiﬁcation of ovarian follicles
Follicle quantiﬁcation was achieved by serial-sectioning at
10 mm of thickness snap-frozen ovaries from each genotype at
PND 3 and 7. Ovarian sections were stained with hematoxylin and
eosin (H&E), photographed and saved as Adobe Photoshop ﬁles.
Only follicles containing oocytes were classiﬁed as either primor-
dial (an oocyte partially or completely encapsulated by ﬂattened
squamous pregranulosa cells) or developing (containing cuboidal
granulosa cells in layers around the oocyte). Every ﬁfth ovarian
section was selected for follicle quantitation. The ﬁnal data
represents the total follicle numbers per section. Comparison
between wild-type controls and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries
was performed by the two-tailed t-test using Microsoft Excel
software. The data are presented as the means7S.E.M. with
n¼3 for both controls and Sf1Cre; Gata4ﬂoxed/ﬂoxed ovaries, and
Po0.05 was considered statistically signiﬁcant.
Cell proliferation and cell death detection assays
Cell proliferation was analyzed by using the synthetic thymi-
dine analog bromodeoxyuridine (BrdU). Mice were injected with
BrdU (Sigma-Aldrich) at a dose of 0.1 mg/g of body weight 2 h
before euthanasia. BrdU incorporation was detected by using anti-
BrdU Alexa Fluor 488-conjugated antibody (Invitrogen). Cell death
was determined either by the terminal deoxynucleotide UTP nick-
end labeling (TUNEL) in situ cell death detection kit (Roche) or a
rabbit-anti mouse active CASP3 antibody (1:300; Abcam). Nuclei
were counterstained with DAPI (Vector Labs).
Super-stimulation protocol
Wild-type controls (n¼4) and Sf1Cre; Gata4ﬂoxed/ﬂoxed (n¼4)
immature mice (PND 30) were subjected to a super-stimulation
protocol with pregnant mare serum gonadotropin (PMSG; 5IU;
Sigma-Aldrich) followed by human chorionic gonadotropin (hCG;
5IU; Sigma-Aldrich) 48 h later. After 24 h of hCG administration,
animals were euthanized and one ovary was ﬁxed in Bouin's (Sigma-
Aldrich) for histological analysis and the other ovary was ﬁxed for
24 h in 4% (w/v) paraformaldehyde for immunoﬂuorescence.Appendix A. Supplementary materials
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.ydbio.2013.06.
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